1.2M
XNAS Volume
High volume+gain today
XNAS 19 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Chrystal U. Louis | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Jason A. Amello | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 270,000 | 270,000 | - | - | Stock Option (Right to Buy) | |
| Barbara Klencke | Director | Purchase of securities on an exchange or from another person at price $ 5.29 per share. | 23 Sep 2024 | 5,000 | 45,000 | - | 5.3 | 26,450 | Voting Common Stock |
| Barbara Klencke | Director | Purchase of securities on an exchange or from another person at price $ 5.53 per share. | 23 Aug 2024 | 5,000 | 40,000 | - | 5.5 | 27,650 | Voting Common Stock |
| Barbara Klencke | Director | Purchase of securities on an exchange or from another person at price $ 5.69 per share. | 23 Aug 2024 | 5,000 | 35,000 | - | 5.7 | 28,450 | Voting Common Stock |
| Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.81 per share. | 23 Aug 2024 | 13,125 | 105,236 | - | 1.8 | 23,756 | Voting Common Stock |
| Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.85 per share. | 23 Aug 2024 | 54,895 | 67,111 | - | 4.9 | 266,241 | Voting Common Stock |
| Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.27 per share. | 23 Aug 2024 | 25,000 | 92,111 | - | 3.3 | 81,750 | Voting Common Stock |
| Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.49 per share. | 23 Aug 2024 | 64,166 | 169,402 | - | 2.5 | 159,773 | Voting Common Stock |
| Zoran Zdraveski | See Remarks | Sale of securities on an exchange or to another person at price $ 5.78 per share. | 23 Aug 2024 | 164,686 | 4,716 | - | 5.8 | 952,116 | Voting Common Stock |
| Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 54,895 | 30,105 | - | - | Stock Option (Right to Buy) | |
| Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 64,166 | 365,834 | - | - | Stock Option (Right to Buy) | |
| Zoran Zdraveski | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 13,125 | 21,875 | - | - | Stock Option (Right to Buy) | |
| Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 23,750 | 23,750 | - | - | Stock Option (Right to Buy) | |
| Katina Dorton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| Robert Keith Woods | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| Gabriela Gruia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| Chrystal U. Louis | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 380,000 | 380,000 | - | - | Stock Option (Right to Buy) | |
| Jason A. Amello | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 750,000 | 750,000 | - | - | Stock Option (Right to Buy) | |
| Leiden Dworak | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 46,875 | 46,875 | - | - | Stock Option (Right to Buy) | |
| Zoran Zdraveski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Zoran Zdraveski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 52,500 | 52,500 | - | - | Stock Option (Right to Buy) | |
| Gavin MacBeath | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 800,000 | 800,000 | - | - | Stock Option (Right to Buy) | |
| Gavin MacBeath | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Timothy J. Barberich | Director | Purchase of securities on an exchange or from another person at price $ 4.97 per share. | 18 Dec 2023 | 317 | 67,027 | - | 5.0 | 1,575 | Voting Common Stock |
| Timothy Barberich J. | Director | Purchase of securities on an exchange or from another person at price $ 4.89 per share. | 18 Dec 2023 | 28,830 | 66,710 | - | 4.9 | 140,881 | Voting Common Stock |
| Klencke Barbara | Director | Purchase of securities on an exchange or from another person at price $ 5.08 per share. | 14 Dec 2023 | 5,000 | 30,000 | - | 5.1 | 25,400 | Voting Common Stock |
| Robert Keith Woods | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Leiden Dworak | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Debora Barton | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 430,000 | 430,000 | - | - | Stock Option (Right to Buy) | |
| Gabriela Gruia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Brian Silver | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 632,500 | 632,500 | - | - | Stock Option (Right to Buy) | |
| Zoran Zdraveski | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 430,000 | 430,000 | - | - | Stock Option (Right to Buy) | |
| Gavin MacBeath | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 1,121,300 | 1,121,300 | - | - | Stock Option (Right to Buy) | |
| Katina Dorton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Timothy J. Barberich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 36,524 | 36,524 | - | - | Stock Option (Right to Buy) | |
| Timothy J. Barberich | Director | Purchase of securities on an exchange or from another person at price $ 2.63 per share. | 02 Jun 2023 | 37,880 | 37,880 | - | 2.6 | 99,564 | Voting Common Stock |
| Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 9,146 | 9,146 | - | - | Stock Option (Right to Buy) | |
| Debora Barton | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Zoran Zdraveski | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Gavin MacBeath | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| David P. Southwell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Brian Silver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.56 per share. | 27 Dec 2022 | 3,158 | 32,885 | - | 1.6 | 4,941 | Voting Common Stock |
| Brian Silver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 27 Dec 2022 | 2,842 | 29,727 | - | 1.5 | 4,276 | Voting Common Stock |
| Zoran Zdraveski | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Gavin MacBeath | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| David P. Southwell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| William Desmarais | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Brian Silver | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 220,000 | 220,000 | - | - | Stock Option (Right to Buy) | |
| Debora Barton | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Gabriela Gruia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 9,146 | 9,146 | - | - | Stock Option (Right to Buy) | |
| Ittai Harel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 9,146 | 9,146 | - | - | Stock Option (Right to Buy) | |
| Katina Dorton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 9,146 | 9,146 | - | - | Stock Option (Right to Buy) | |
| Timothy J. Barberich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 9,146 | 9,146 | - | - | Stock Option (Right to Buy) | |
| David P. Southwell | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.55 per share. | 18 May 2022 | 10,000 | 171,569 | - | 3.5 | 35,482 | Voting Common Stock |
| David P. Southwell | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.62 per share. | 18 May 2022 | 15,000 | 161,569 | - | 3.6 | 54,339 | Voting Common Stock |
| Brian Silver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.40 per share. | 24 Mar 2022 | 15,000 | 26,885 | - | 3.4 | 50,982 | Voting Common Stock |
| Brian Silver | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Gavin MacBeath | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy) | |
| Zoran Zdraveski | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| David P. Southwell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| William Desmarais | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| David P. Southwell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.97 per share. | 23 Dec 2021 | 48,670 | 146,569 | - | 2.0 | 95,880 | Voting Common Stock |
| David P. Southwell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2021 | 48,670 | 21,161 | - | - | Stock Option (Right to Buy) | |
| Brian Silver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 6.32 per share. | 21 Sep 2021 | 5,000 | 11,885 | - | 6.3 | 31,585 | Voting Common Stock |
| Gavin MacBeath | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 6.22 per share. | 20 Sep 2021 | 4,943 | 49,710 | - | 6.2 | 30,744 | Voting Common Stock |
| Gavin MacBeath | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 6.19 per share. | 20 Sep 2021 | 57 | 49,767 | - | 6.2 | 353 | Voting Common Stock |
| Brian Silver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 8.48 per share. | 09 Sep 2021 | 5,885 | 6,885 | - | 8.5 | 49,925 | Voting Common Stock |
| David P. Southwell | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 8.73 per share. | 08 Sep 2021 | 11,000 | 97,899 | - | 8.7 | 96,066 | Voting Common Stock |
| William Desmarais | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 9.08 per share. | 27 Aug 2021 | 2,500 | 2,500 | - | 9.1 | 22,708 | Voting Common Stock |
| Timothy J. Barberich | Director | 20 Jul 2021 | 33,259 | 33,259 | - | - | Voting Common Stock | ||
| Timothy J. Barberich | Director | 20 Jul 2021 | 33,259 | 0 | - | - | Series B Preferred Stock | ||
| Christoph H. Westphal | Ten Percent Owner | 20 Jul 2021 | 171,063 | 0 | - | - | Series C Preferred Stock | ||
| Christoph H. Westphal | Ten Percent Owner | 20 Jul 2021 | 332,594 | 0 | - | - | Series B Preferred Stock | ||
| Christoph H. Westphal | Ten Percent Owner | 20 Jul 2021 | 641,848 | 0 | - | - | Series A Preferred Stock | ||
| Christoph H. Westphal | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 20 Jul 2021 | 133,333 | 1,278,838 | - | 15 | 1,999,995 | Voting Common Stock |
| Christoph H. Westphal | Ten Percent Owner | 20 Jul 2021 | 1,145,505 | 1,145,505 | - | - | Voting Common Stock | ||
| Gabriela Gruia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 9,146 | 9,146 | - | - | Stock Option (right to buy) | |
| Brian Silver | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 15 Jul 2021 | 1,000 | 1,000 | - | 15 | 15,000 | Voting Common Stock |
| Brian Silver | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 250,441 | 250,441 | - | - | Stock Option (right to buy) | |
| Gabriela Gruia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 9,146 | 9,146 | - | - | Stock Option (right to buy) |